Independent consulting from a practicing clinical pharmacist working the access and reimbursement problem from the inside: prior authorization, payer policy, PBM structure, and the emerging GLP-1/peptide landscape. Advisory work, expert network consultations, and published policy analysis.
Each area feeds the others — benefit verification work surfaces the PBM and policy patterns that show up in the writing and advisory calls.
Prior authorization strategy and payer policy navigation for specialty and biologic drugs, built from direct clinical coverage-determination experience.
Evaluating and designing benefit verification workflows and technology, drawn from hands-on work building a multi-phase verification playbook and tooling.
DIR fees, white and brown bagging, preferred network exclusions, and the independent pharmacy pressure points these create.
Medicare bridge program mechanics, peptide reclassification policy, and counseling and access pathways as this category moves fast.